Open Access
Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
Publication type: Journal Article
Publication date: 2017-10-25
scimago Q1
wos Q1
SJR: 1.380
CiteScore: 16.4
Impact factor: 8.1
ISSN: 10717544, 15210464
PubMed ID:
29069920
General Medicine
Pharmaceutical Science
Abstract
Abstract To prolong the circulation time of drug, PEGylation has been widely used via the enhanced permeability and retention (EPR) effect, thereby providing new hope for better treatment. However, PEGylation also brings the "PEG dilemma", which is difficult for the cellular absorption of drugs and subsequent endosomal escape. As a result, the activity of drugs is inevitably lost after PEG modification. To achieve successful drug delivery for effective treatment, the crucial issue associated with the use of PEG-lipids, that is, “PEG dilemma” must be addressed. In this paper, we introduced the development and application of nanocarriers with cleavable PEGylation, and discussed various strategies for overcoming the PEG dilemma. Compared to the traditional ones, the vehicle systems with different environmental-sensitive PEG-lipids were discussed, which cleavage can be achieved in response to the intracellular as well as the tumor microenvironment. This smart cleavable PEGylation provides us an efficient strategy to overcome “PEG dilemma”, thereby may be a good candidate for the cancer treatment in future.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
20
|
|
|
Journal of Controlled Release
19 publications, 5.97%
|
|
|
Pharmaceutics
13 publications, 4.09%
|
|
|
International Journal of Molecular Sciences
7 publications, 2.2%
|
|
|
International Journal of Pharmaceutics
7 publications, 2.2%
|
|
|
Nanomedicine
6 publications, 1.89%
|
|
|
Nanomaterials
6 publications, 1.89%
|
|
|
Advanced healthcare materials
6 publications, 1.89%
|
|
|
Journal of Materials Chemistry B
6 publications, 1.89%
|
|
|
International Journal of Biological Macromolecules
5 publications, 1.57%
|
|
|
Acta Biomaterialia
5 publications, 1.57%
|
|
|
Journal of Drug Targeting
5 publications, 1.57%
|
|
|
Expert Opinion on Drug Delivery
5 publications, 1.57%
|
|
|
Polymers
4 publications, 1.26%
|
|
|
Colloids and Surfaces A: Physicochemical and Engineering Aspects
3 publications, 0.94%
|
|
|
Molecules
3 publications, 0.94%
|
|
|
Drug Delivery and Translational Research
3 publications, 0.94%
|
|
|
European Polymer Journal
3 publications, 0.94%
|
|
|
European Journal of Pharmaceutics and Biopharmaceutics
3 publications, 0.94%
|
|
|
Advanced Drug Delivery Reviews
3 publications, 0.94%
|
|
|
Drug Discovery Today
3 publications, 0.94%
|
|
|
Acta Pharmaceutica Sinica B
3 publications, 0.94%
|
|
|
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
3 publications, 0.94%
|
|
|
Advanced Science
3 publications, 0.94%
|
|
|
ACS Nano
3 publications, 0.94%
|
|
|
Biomacromolecules
3 publications, 0.94%
|
|
|
Biomaterials Science
3 publications, 0.94%
|
|
|
Langmuir
3 publications, 0.94%
|
|
|
Biomedicine and Pharmacotherapy
3 publications, 0.94%
|
|
|
Small
3 publications, 0.94%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
Publishers
|
10
20
30
40
50
60
70
80
90
100
|
|
|
Elsevier
97 publications, 30.5%
|
|
|
MDPI
38 publications, 11.95%
|
|
|
Wiley
33 publications, 10.38%
|
|
|
Springer Nature
32 publications, 10.06%
|
|
|
American Chemical Society (ACS)
28 publications, 8.81%
|
|
|
Taylor & Francis
25 publications, 7.86%
|
|
|
Royal Society of Chemistry (RSC)
24 publications, 7.55%
|
|
|
Frontiers Media S.A.
9 publications, 2.83%
|
|
|
Cold Spring Harbor Laboratory
5 publications, 1.57%
|
|
|
Bentham Science Publishers Ltd.
4 publications, 1.26%
|
|
|
Spandidos Publications
2 publications, 0.63%
|
|
|
Public Library of Science (PLoS)
2 publications, 0.63%
|
|
|
Oxford University Press
2 publications, 0.63%
|
|
|
Beilstein-Institut
2 publications, 0.63%
|
|
|
AIP Publishing
1 publication, 0.31%
|
|
|
American Scientific Publishers
1 publication, 0.31%
|
|
|
SAGE
1 publication, 0.31%
|
|
|
Shenyang Pharmaceutical University
1 publication, 0.31%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 0.31%
|
|
|
Open Exploration Publishing
1 publication, 0.31%
|
|
|
Hindawi Limited
1 publication, 0.31%
|
|
|
Pleiades Publishing
1 publication, 0.31%
|
|
|
IOP Publishing
1 publication, 0.31%
|
|
|
Mary Ann Liebert
1 publication, 0.31%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.31%
|
|
|
IntechOpen
1 publication, 0.31%
|
|
|
Science in China Press
1 publication, 0.31%
|
|
|
10
20
30
40
50
60
70
80
90
100
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
318
Total citations:
318
Citations from 2024:
110
(34.6%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Fang Y. et al. Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery // Drug Delivery. 2017. Vol. 24. No. 2. pp. 22-32.
GOST all authors (up to 50)
Copy
Fang Y., Xue J., Gao S., Lu A., Yang D., Jiang H., Yang H., SHI K. Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery // Drug Delivery. 2017. Vol. 24. No. 2. pp. 22-32.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/10717544.2017.1388451
UR - https://doi.org/10.1080/10717544.2017.1388451
TI - Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
T2 - Drug Delivery
AU - Fang, Yan
AU - Xue, Jianxiu
AU - Gao, Shan
AU - Lu, Anqi
AU - Yang, Dongjuan
AU - Jiang, Hong
AU - Yang, He
AU - SHI, KAI
PY - 2017
DA - 2017/10/25
PB - Taylor & Francis
SP - 22-32
IS - 2
VL - 24
PMID - 29069920
SN - 1071-7544
SN - 1521-0464
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Fang,
author = {Yan Fang and Jianxiu Xue and Shan Gao and Anqi Lu and Dongjuan Yang and Hong Jiang and He Yang and KAI SHI},
title = {Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery},
journal = {Drug Delivery},
year = {2017},
volume = {24},
publisher = {Taylor & Francis},
month = {oct},
url = {https://doi.org/10.1080/10717544.2017.1388451},
number = {2},
pages = {22--32},
doi = {10.1080/10717544.2017.1388451}
}
Cite this
MLA
Copy
Fang, Yan, et al. “Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery.” Drug Delivery, vol. 24, no. 2, Oct. 2017, pp. 22-32. https://doi.org/10.1080/10717544.2017.1388451.